Successful treatment of murine listeriosis and salmonellosis with levofloxacin

Journal of Chemotherapy

Volumn 10, Issue 4, 1998, Pages 313-319

  Nichterlein, T ^a   Bornitz, F ^a   Kretschmar, M ^a   Hof, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antibiotics; Infection; Levofloxacin; Listeria monocytogenes

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

EID: 0031852241     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.4.313     Document Type: Article

References (20)

1. Piddock LJV. New quinolones and gram-positive bacteria. Antimicrob Agents Chemother 1994; 38: 163-169.
2. Rubinstein E, Carbon C. The fluoroquinolones-reappraisal. J Antimicrob Agents 1992; 1: 147-152.
3. Morrissey I, Hoshino K, Sato K, et al. Mechanism of differential activities of ofloxacin enantiomers. Antimicrob Agents Chemother 1996; 40: 1775-1784.
4. Cherubin CE, Stratton CW. Assessment of the bactericidal activity of sparfloxacin, ofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes. Diagn Microbiol Infect Dis 1994; 20: 21-25.
5. Yamane N, Jones RN, Frei R, Hoban DJ, Pignatari AC, Marco F. Levofloxacin in vitro activity: results of an international comparative study with ofloxacin and ciprofloxacin. J Chemother 1994; 6: 83-91.
6. Avril JL, Couete I, Travert MF, Autuly F, Plessis P. Sensibilite aux quinolones des Salmonella isolees chez l' homme et l'animal. Pathol Biol Paris 1995; 43: 270-273.
7. Zhang YY, Wang F, Zhang JD, Zhou L. In vitro antibacterial activity of levofloxacin. Drugs 1995; 49 (Suppl. 2): 274-275.
8. Mor N, Vanderkolk J, Heifets L. Inhibition an bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages. Antimicrob Agents Chemother 1994; 38: 1161-1164.
9. Klesel N, Geweniger KH, Koletzki P, et al. Chemotherapeutic activity of levofloxacin (HR 355, DR 3355) against systemic and localized infections in laboratory animals. J Antimicrob Chemother 1995; 35: 805-819.
10. Portnoy DA. Innate immunity to a facultative intracellular pathogen. Curr Opin Immunol 1992; 4: 20-24.
11. Skogberg, K, Syrjänen J, Jahkola M, et al. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis 1992; 14: 815-821.
12. Dunlap NE, Benjamin NH, Briles DE. The intracellular nature of salmonella infection during the early stages of mouse typhoid. In: Zwilling BS, Eisenstein TK, eds. Macrophage-pathogen-interactions. New York: Marcel Dekker, 1994: 303-312.
13. Nichterlein T, Kretschmar M, Budeanu C, Bauer J, Linss W, Hof H. Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L 929 cells. Antimicrob Agents Chemother 1994; 38: 1501-1506.
14. Woods GL, Washington JA. Antibacterial susceptibility tests: Dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology. Washington, DC: ASM Press 1995: 1327-1341.
15. Peterson LR, Shanholtzer CJ. Tests for bactericidal effects of antimicrobial agents: technical performances and clinical relevance. Clin Microbiol Rev 1992; 5: 420-432.
16. Michelet C, Avril JL, Arvieux C, Jaquelinet C, Vu N, Cartier F. Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampicin, against intracellular Listeria monocytogenes. Antimicrob Agents Chemother 1997; 41: 60-65.
17. Garcia I, Pascual A, Conejo MC, Perea EJ. Intracellular penetration of 5 quinolones into non-phagocytic cells. Enferm Infec Microbiol Clin 1996; 14: 167-170.
18. Jones EM, MacGowan AP. Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. Eur J Clin Microbiol Infect Dis 1995; 14: 165-175.
19. Hof H, Nichterlein T, Kretschmar M. Management of listeriosis. Clin Microbiol Rev 1997; 10: 345-357.
20. McLaughlin J, Audurier A, Taylor AG. Treatment failure of recurrent human listeriosis. J Antimicrob Chemother 1991; 27: 851-857.